Nasal naloxone remains expensive relative to the cost of the underlying drug and continues to strain budgets of public health ...
If an HHS Secretary can seek to unilaterally overturn an evidence-based standard of transgender health care, the same can ...
Similar to opioids and intoxicating hemp-derived THC products, a well-funded and growing kratom industry with lobbying power ...
Using heart failure as an example, we explore technical issues with episode-based payments that are best resolved within the ...
This article concludes a series of five articles on the final 2027 payment rule. It also covers a new lawsuit seeking to void ...
Given the high stakes involved, the generic exclusivity period’s effects on competition should be scrutinized.
The new rule implementing HR 1’s Medicaid community engagement provision diverges from state expectations. No last-minute ...
The framework that the forthcoming Long-term Enhanced ACO Design (LEAD) Model operates within is the FFS framework, which was ...
That most states have exceeded their cost growth targets is not evidence that the targets have failed—it is evidence that ...
The DoJ intervened in the whistleblower lawsuit, alleging that the MA Organizations paid the broker defendants hundreds of ...
If any institution can bend the curve on preventable stillbirth, it is the American College of Obstetricians and ...
We should keep grading hospitals. We must also imagine measurement structures as intelligent as the systems they evaluate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results